000 | 01615 a2200445 4500 | ||
---|---|---|---|
005 | 20250511014443.0 | ||
264 | 0 | _c19790523 | |
008 | 197905s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm00188a008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPortoghese, P S | |
245 | 0 | 0 |
_aSynthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist properties. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cFeb 1979 |
||
300 |
_a168-73 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAlkylating Agents _xchemical synthesis |
650 | 0 | 4 | _aAnalgesics |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMolecular Conformation |
650 | 0 | 4 |
_aMorphine _xantagonists & inhibitors |
650 | 0 | 4 |
_aMorphine Dependence _xprevention & control |
650 | 0 | 4 |
_aNaloxone _xanalogs & derivatives |
650 | 0 | 4 |
_aNaltrexone _xanalogs & derivatives |
650 | 0 | 4 |
_aNarcotic Antagonists _xchemical synthesis |
650 | 0 | 4 |
_aNitrogen Mustard Compounds _xchemical synthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReceptors, Opioid _xmetabolism |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aLarson, D L | |
700 | 1 | _aJiang, J B | |
700 | 1 | _aCaruso, T P | |
700 | 1 | _aTakemori, A E | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 22 _gno. 2 _gp. 168-73 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00188a008 _zAvailable from publisher's website |
999 |
_c213513 _d213513 |